Friday, January 19, 2018 10:15 PM ET
Insider Sale at FibroGen (FGEN) Continues Selling Trend
There was a significant insider sale of FibroGen shares today, as indicated in a filing with the SEC as — Thomas B Neff, Director and Officer — sold 38,636 shares in the company having a market value of approximately $1,833,514. There have been 5 insiders with buy/sell transactions in the past 90 days prior to this filing. These trades have resulted in the acquisition of 3,500 company shares and the sale of 171,746 company shares over this time period. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 206,882 shares and have averaged 35,647 shares per transaction over this time period.
Over the last 90 days, the number of insider buy/sell trades at FibroGen is above its 191-company peer group average. The Biotechnology & Medical Research peer group saw 156 buy/sell trades during this period for an average of 0.8 transactions per company. However, the number of shares traded per transaction by FibroGen insiders is lower than its peers. Within the peer group there were 25,652,544 shares purchased and 11,452,606 shares sold with company insiders acquiring 130,275 shares on average over this time period.
Significant insider buying and selling activity has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in data sourced in evaluating and writing this story.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.